Elena Ridloff, Director at Kymera Therapeutics, Inc. (KYMR), sold 12,000 shares at $47.00 ($553K) on 2025-06-03, disclosed to the SEC on 2025-06-03.
Scheduled sale ($553k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.50 | 7,200 | $328K | 59.2% |
| 2 | $47.00 | 4,800 | $226K | 40.8% |
| Total | $46.10 avg | 12,000 | $553K | 100% |
| Filing → |
| SION | SELL | 2025-09-03 | $462K | — | Filing → |
| SION | SELL | 2025-08-28 | $1.1M | — | Filing → |
| SION | SELL | 2025-08-21 | $1.9M | — | Filing → |